Edition:
United Kingdom

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

35.67CAD
23 Feb 2018
Change (% chg)

$0.23 (+0.65%)
Prev Close
$35.44
Open
$35.86
Day's High
$35.90
Day's Low
$35.13
Volume
173,283
Avg. Vol
373,511
52-wk High
$46.00
52-wk Low
$7.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jul '17 4.77 -0.060
Apr '17 3.69 -0.082
Jan '17 3.41 -0.194
FY 2016 Oct '16 3.16 -0.784
Jul '16 2.65 -0.032
Apr '16 2.22 -0.019
Jan '16 1.76 -0.065
 
*Note: Units in Millions ofCanadian Dollars
**Note: Units in Canadian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 2 6.25 7.30 5.20 --
Quarter Ending Apr-18 1 9.50 9.50 9.50 --
Year Ending Oct-18 2 38.50 42.20 34.80 --
Year Ending Oct-19 4 109.88 195.20 68.60 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.07 -0.07 -0.07 --
Year Ending Oct-18 2 -0.07 0.13 -0.27 --
Year Ending Oct-19 4 1.11 1.62 0.74 --
Sales and Profit Figures in Canadian Dollar (CAD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 17.41 3.98 5.77
Price to Book (MRQ) 2.92 4.84 5.41
Price to Tangible Book (MRQ) 2.98 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions -- 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 80.00 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago 84.97 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -85.24 16.65 19.66
EPS (TTM) vs TTM 1 Yr. Ago -602.08 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 10.24 2.11 2.18
Current Ratio (MRQ) 12.30 2.89 2.97
LT Debt to Equity (MRQ) 12.52 9.91 12.22
Total Debt to Equity (MRQ) 15.36 13.93 16.52
Interest Coverage (TTM) -3.38 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 39.01 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -31.44 -- --
EBITD - 5 Yr. Avg -- 18.51 10.86
Operating Margin (TTM) -95.02 14.36 4.64
Operating Margin - 5 Yr. Avg. -- 14.42 6.26
Pre-Tax Margin (TTM) -104.51 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 14.73 6.60
Net Profit Margin (TTM) -100.58 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 948,744,532 855,673,508
Net Income/Employee (TTM) -- 111,622,899 100,656,226
Receivable Turnover (TTM) 11.54 5.62 5.78
Inventory Turnover (TTM) 1.03 2.58 3.35
Asset Turnover (TTM) 0.19 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -18.85 11.45 10.98
Return on Assets - 5 Yr. Avg. -- 12.98 12.37
Return on Investment (TTM) -22.66 14.91 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) -28.19 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % 69.26 -5.05 --
EPS (TTM) % -238.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CanniMed Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.68%
# of Holders: 14
Total Shares Held: 8,338,819
3 Mo. Net Change: 829,141
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.